• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌相关性萎缩性胃炎的侵入性与非侵入性诊断:一项对比研究。

Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study.

作者信息

Pasechnikov Victor D, Chukov Sergey Z, Kotelevets Sergey M, Mostovov Alexander N, Mernova Varvara P, Polyakova Maria B

机构信息

Department of Therapy, Stavropol Medical Academy, Stavropol, Russia.

出版信息

Scand J Gastroenterol. 2005 Mar;40(3):297-301. doi: 10.1080/00365520410010607.

DOI:10.1080/00365520410010607
PMID:15932170
Abstract

OBJECTIVE

Helicobacter pylori-associated atrophic gastritis is known to be a significant risk factor for gastric cancer. Among the well-known parameters of atrophic gastritis are the levels of serum gastrin-17 (G-17) and pepsinogen I (PG1), which are biomarkers of gastric antral and corpus mucosal activity, respectively. The aim of study was to compare the production of G-17 and PG1 in patients with or without stomach mucosal atrophy and to investigate the utility of serum PG1 and/or G-17 concentrations for the objective evaluation of atrophic gastritis.

MATERIAL AND METHODS

A total of 178 dyspeptic Helicobacter pylori-positive patients underwent diagnostic upper gastrointestinal endoscopy with biopsy. The degree of histologic gastric mucosal atrophy was compared with the fasting levels of PG1, and to the postprandial levels of G-17 detected by enzyme immunoassay.

RESULTS

A decrease in serum G-17 levels along with worsening of the antral atrophy was observed; the serum levels of PG1 were reduced during progression of the corpus atrophy. In the multifocal atrophic gastritis, values for PG1 and G-17 serum concentrations were significantly lower than the respective cut-off values. Statistical analysis revealed statistically significant differences between the serum levels of PG1 and G-17 measured at different stages of stomach mucosal atrophy.

CONCLUSIONS

A strong reverse correlation was found between histologic/ endoscopic antral atrophy and serum G-17 levels, and between corpus atrophy and serum PG1 levels.

摘要

目的

幽门螺杆菌相关性萎缩性胃炎是胃癌的一个重要危险因素。萎缩性胃炎的一些知名参数包括血清胃泌素-17(G-17)和胃蛋白酶原I(PG1)水平,它们分别是胃窦和胃体黏膜活性的生物标志物。本研究的目的是比较有无胃黏膜萎缩患者的G-17和PG1产生情况,并探讨血清PG1和/或G-17浓度在客观评估萎缩性胃炎中的作用。

材料与方法

共178例幽门螺杆菌阳性的消化不良患者接受了诊断性上消化道内镜检查及活检。将组织学胃黏膜萎缩程度与PG1的空腹水平以及通过酶免疫测定法检测的餐后G-17水平进行比较。

结果

观察到随着胃窦萎缩加重,血清G-17水平下降;在胃体萎缩进展过程中,PG1血清水平降低。在多灶性萎缩性胃炎中,PG1和G-17血清浓度值显著低于各自的临界值。统计分析显示,在胃黏膜萎缩不同阶段测量的PG1和G-17血清水平之间存在统计学显著差异。

结论

发现组织学/内镜下胃窦萎缩与血清G-17水平之间以及胃体萎缩与血清PG1水平之间存在强烈的负相关。

相似文献

1
Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study.幽门螺杆菌相关性萎缩性胃炎的侵入性与非侵入性诊断:一项对比研究。
Scand J Gastroenterol. 2005 Mar;40(3):297-301. doi: 10.1080/00365520410010607.
2
Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.通过血液检测对萎缩性胃炎进行非内镜诊断。胃组织学与胃泌素-17和胃蛋白酶原I血清水平之间的相关性:一项多中心研究。
Eur J Gastroenterol Hepatol. 2003 Aug;15(8):885-91. doi: 10.1097/00042737-200308000-00009.
3
Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.萎缩性胃炎患者血清中酰胺化胃泌素-17和胃蛋白酶原I水平:一项观察性病例对照研究。
Scand J Gastroenterol. 2002 Jul;37(7):785-91.
4
Morpho-functional comparisons in Helicobacter pylori-associated chronic atrophic gastritis.幽门螺杆菌相关性慢性萎缩性胃炎的形态功能比较
Rocz Akad Med Bialymst. 2005;50:183-7.
5
The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.中国组织学胃炎分期-“OLGA/OLGIM”与血清胃蛋白酶原检测在评估胃萎缩/肠化生中的相关性
Scand J Gastroenterol. 2017 Aug;52(8):822-827. doi: 10.1080/00365521.2017.1315739. Epub 2017 Apr 22.
6
Helicobacter pylori infection and atrophic gastritis.幽门螺杆菌感染与萎缩性胃炎。
Afr Health Sci. 2013 Mar;13(1):112-7. doi: 10.4314/ahs.v13i1.15.
7
Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.多灶萎缩性胃炎的非内镜诊断;血清胃泌素-17、胃蛋白酶原及幽门螺杆菌抗体的诊断效能
Acta Gastroenterol Belg. 2004 Oct-Dec;67(4):320-6.
8
[Potentialities of a serological method in diagnosis of atrophic gastritis].[血清学方法在萎缩性胃炎诊断中的潜力]
Ter Arkh. 2008;80(2):15-21.
9
GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.用于消化不良患者萎缩性胃炎无创诊断的GastroPanel®检测
Minerva Gastroenterol Dietol. 2014 Mar;60(1):79-83.
10
The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis.预测经组织学证实的萎缩性胃炎的最佳血清胃蛋白酶原临界值。
Dig Liver Dis. 2015 Aug;47(8):663-8. doi: 10.1016/j.dld.2015.05.014. Epub 2015 May 23.

引用本文的文献

1
Point-of-Care Diagnosis of Atrophic Gastritis by Serological Biomarker Test (GastroPanel Quick Test) in Gastroscopy Referral Patients in India.印度胃镜转诊患者中通过血清生物标志物检测(胃功能三项快速检测)进行萎缩性胃炎的即时诊断
J Clin Med. 2025 Jan 25;14(3):787. doi: 10.3390/jcm14030787.
2
Can GastroPanel be used as a triage tool to select patients with advanced atrophic gastritis for gastroscopy? A prospective clinical validation study.GastroPanel能否用作筛选晚期萎缩性胃炎患者进行胃镜检查的分诊工具?一项前瞻性临床验证研究。
BMJ Open Gastroenterol. 2025 Jan 6;12(1):e001559. doi: 10.1136/bmjgast-2024-001559.
3
Chronic atrophic gastritis: an update on diagnosis.
慢性萎缩性胃炎:诊断进展
Med Pharm Rep. 2021 Jan;94(1):7-14. doi: 10.15386/mpr-1887. Epub 2021 Jan 29.
4
Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.采用 OLGA 系统评估智利人群的胃炎和胃癌风险。
Pathol Oncol Res. 2019 Jul;25(3):1135-1142. doi: 10.1007/s12253-018-0532-3. Epub 2018 Nov 22.
5
Immunopathological and Modulatory Effects of Genotype on Gastric Mucosa, Inflammatory Response, Pepsinogens, and Gastrin-17 Secretion in Iraqi Patients infected with .基因型对感染幽门螺杆菌的伊拉克患者胃黏膜、炎症反应、胃蛋白酶原和胃泌素-17分泌的免疫病理及调节作用
Open Access Maced J Med Sci. 2018 May 14;6(5):794-802. doi: 10.3889/oamjms.2018.178. eCollection 2018 May 20.
6
Gastric cancer: prevention, screening and early diagnosis.胃癌:预防、筛查与早期诊断
World J Gastroenterol. 2014 Oct 14;20(38):13842-62. doi: 10.3748/wjg.v20.i38.13842.
7
Pepsinogen II can be a potential surrogate marker of morphological changes in corpus before and after H. pylori eradication.胃蛋白酶原 II 可作为 H. pylori 根除前后胃体形态变化的潜在替代标志物。
Biomed Res Int. 2014;2014:481607. doi: 10.1155/2014/481607. Epub 2014 Jun 17.
8
Helicobacter pylori infection and atrophic gastritis.幽门螺杆菌感染与萎缩性胃炎。
Afr Health Sci. 2013 Mar;13(1):112-7. doi: 10.4314/ahs.v13i1.15.
9
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).胃黏膜癌前病变和病灶的处理(MAPS):欧洲胃肠道内镜学会(ESGE)、欧洲幽门螺杆菌研究组(EHSG)、欧洲病理学会(ESP)和葡萄牙消化内镜学会(SPED)指南
Endoscopy. 2012 Jan;44(1):74-94. doi: 10.1055/s-0031-1291491. Epub 2011 Dec 23.
10
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).胃黏膜癌前状态和病变的管理(MAPS):欧洲胃肠道内镜学会(ESGE)、欧洲幽门螺杆菌研究组(EHSG)、欧洲病理学会(ESP)和葡萄牙消化内镜学会(SPED)的指南。
Virchows Arch. 2012 Jan;460(1):19-46. doi: 10.1007/s00428-011-1177-8. Epub 2011 Dec 22.